-
Symbol
-
RVNC
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.001 per share
-
Latest Disclosed Ownership
-
6.55M shares
-
Security Ownership
-
6.2%
Teoxane SA ownership in Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)
2025-01-30 - Teoxane SA has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.55M shares of Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC).
This represents 6.2% percent ownership of the company.